Folgen
Nazanin Mirzaei
Nazanin Mirzaei
Life Molecular Imaging, Imperial College London, Cedars-Sinai Medical Center
Bestätigte E-Mail-Adresse bei life-mi.com
Titel
Zitiert von
Zitiert von
Jahr
PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model
L Katsouri, YM Lim, K Blondrath, I Eleftheriadou, L Lombardero, AM Birch, ...
Proceedings of the National Academy of Sciences 113 (43), 12292-12297, 2016
1372016
Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina
H Shi, Y Koronyo, A Rentsendorj, GC Regis, J Sheyn, DT Fuchs, ...
Acta neuropathologica 139, 813-836, 2020
1292020
Activation of the Wnt/β‐catenin pathway represses the transcription of the β‐amyloid precursor protein cleaving enzyme (BACE1) via binding of T‐cell factor‐4 to BACE1 promoter
C Parr, N Mirzaei, M Christian, M Sastre
The FASEB journal 29 (2), 623-635, 2015
1032015
In vivo imaging of microglial activation by positron emission tomography with [11C]PBR28 in the 5XFAD model of Alzheimer's disease
N Mirzaei, SP Tang, S Ashworth, C Coello, C Plisson, J Passchier, ...
Glia 64 (6), 993-1006, 2016
922016
Cascades and cognitive state: focused attention incurs subcritical dynamics
ED Fagerholm, R Lorenz, G Scott, M Dinov, PJ Hellyer, N Mirzaei, ...
Journal of Neuroscience 35 (11), 4626-4634, 2015
912015
Alzheimer’s retinopathy: seeing disease in the eyes
N Mirzaei, H Shi, M Oviatt, J Doustar, KL Black, M Koronyo-Hamaoui
Frontiers in neuroscience 14, 566483, 2020
802020
Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer's disease
L Katsouri, AM Birch, AWJ Renziehausen, C Zach, Y Aman, H Steeds, ...
Glia 68 (5), 1017-1030, 2020
672020
Systemic administration of fibroblast growth factor-2 (FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice
L Katsouri, A Ashraf, AM Birch, KKL Lee, N Mirzaei, M Sastre
Neurobiology of aging 36 (2), 821-831, 2015
512015
Retinal vasculopathy in Alzheimer’s disease
H Shi, Y Koronyo, A Rentsendorj, DT Fuchs, J Sheyn, KL Black, N Mirzaei, ...
Frontiers in neuroscience 15, 731614, 2021
442021
Parallels between retinal and brain pathology and response to immunotherapy in old, late‐stage Alzheimer's disease mouse models
J Doustar, A Rentsendorj, T Torbati, GC Regis, DT Fuchs, J Sheyn, ...
Aging Cell 19 (11), e13246, 2020
322020
Retinal pathological features and proteome signatures of Alzheimer’s disease
Y Koronyo, A Rentsendorj, N Mirzaei, GC Regis, J Sheyn, H Shi, E Barron, ...
Acta Neuropathologica 145 (4), 409-438, 2023
272023
Dose-dependent neuroprotection of VEGF165 in Huntington's disease striatum
SM Ellison, A Trabalza, V Tisato, E Pazarentzos, S Lee, V Papadaki, ...
Molecular Therapy 21 (10), 1862-1875, 2013
252013
Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease
N Mirzaei, BC Mota, AM Birch, N Davis, C Romero‐Molina, L Katsouri, ...
British Journal of Pharmacology 178 (3), 654-671, 2021
122021
Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid β-protein and phosphorylated tau
X Du, Y Koronyo, N Mirzaei, C Yang, DT Fuchs, KL Black, ...
PNAS nexus 1 (4), pgac164, 2022
102022
Imaging of Microglial Activation in Alzheimer’s Disease by [11C]PBR28 PET
CK Donat, N Mirzaei, SP Tang, P Edison, M Sastre
Biomarkers for Alzheimer’s Disease Drug Development, 323-339, 2018
82018
Astrocyte reactivity in Alzheimer's disease: Therapeutic opportunities to promote repair
N Mirzaei, N Davis, TW Chau, M Sastre
Current Alzheimer Research 19 (1), 1-15, 2022
62022
Retinal vascular abnormalities and blood‐retinal barrier breakdown in Alzheimer’s disease
M Koronyo‐Hamaoui, H Shi, A Rentsendorj, DT Fuchs, J Sheyn, ...
Alzheimer's & Dementia 17, e056603, 2021
12021
Retinal tauopathy colocalizes in sites of synaptic loss in patients with mild cognitive impairment and Alzheimer’s disease
N Mirzaei, J Sheyn, A Rentsendorj, DT Fuchs, MR Davis, ML Selenica, ...
Investigative Ophthalmology & Visual Science 62 (8), 3079-3079, 2021
12021
Evaluation of [3H] PBR28 as a marker of microglial activation in the rat controlled cortical impact model of traumatic brain injury
N Mirzaei, R de Burgh, D Sharp, M Sastre
BRAIN INJURY 30 (5-6), 608-608, 2016
12016
Identification of retinal tau oligomers, citrullinated tau, and other tau isoforms in early and advanced AD and relations to disease status
H Shi, N Mirzaei, Y Koronyo, MR Davis, E Robinson, GM Braun, O Jallow, ...
bioRxiv, 2024
2024
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20